738 online
 
Most Popular Choices
Share on Facebook 61 Printer Friendly Page More Sharing Summarizing
OpEdNews Op Eds   

We cannot #endAIDS if we blindly depend on the Global North

By       (Page 3 of 3 pages) Become a premium member to see this article and all articles as one long page.   No comments

Citizen News Service - CNS
Follow Me on Twitter     Message Citizen News Service - CNS
Become a Fan
  (2 fans)

Dr Glory Alexander, who is the founder of ASHA Foundation in India and elected as Vice President of AIDS Society of India (ASI), is also a part of the AIDS 2022 organizing committee. She said that "over the years, we have been able to reduce the number of new HIV infections by about 37% since 2010, and decreased AIDS-related deaths by 66% since 2010 in India. That is huge achievement and was possible largely due to scale up of antiretroviral therapy."

However, "among the key populations, HIV seroprevalence continues to remain very high - between 1.5% to 6.25% (compared to general population where HIV incidence is around 0.21%). This needs to be reduced before we can even think of achieving #endAIDS targets. Along with scaling up HIV care services we also have to reduce inequities, failing which it will be very difficult to reach out to the targets of 100-100-100 by 2030" said Dr Glory Alexander to CNS (Citizen News Service).

Dr Glory's concern regarding high HIV rate among key populations is also echoed by the United Nations joint programme on HIV/AIDS (UNAIDS). According to the UNAIDS, the risk of acquiring HIV is 35 times higher among people who inject drugs than adults who do not inject drugs; 30 times higher for female sex workers than adult women; 28 times higher among gay men and other men who have sex with men than adult men; and 14 times higher for transgender women than adult women.

Dr Ishwar Gilada rightly pointed out that it is not 'Global North vs Global South', but a call for reimagining the fight to end AIDS based on principles of solidarity, equity, and social justice. While Global North currently leads on health innovations, it is no less vital to ensure that these scientific breakthroughs reach the most-in-need people globally without any delay (or without any barriers like cost).

Bobby Ramakant - CNS (Citizen News Service)

(Bobby Ramakant is a World Health Organization (WHO) Director General's WNTD Awardee 2008 and part of editorial of CNS (Citizen News Service). Follow him on Twitter @BobbyRamakant or visit www.bit.ly/BobbyRamakant)

- Shared under Creative Commons (CC)

Next Page  1  |  2  |  3

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Rate It | View Ratings

Citizen News Service - CNS Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Citizen News Service (CNS) specializes in in-depth and rights-based, health and science journalism. For more information, please contact: www.citizen-news.org or @cns_health or www.facebook.com/cns.page
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter

Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

The chasm between TB and HIV continues

Management of respiratory diseases beyond drugs: Pulmonary Rehabilitation

Oxygen therapy is like a prescription drug: Use it rationally

New funding boosts research for controlling TB, malaria, dengue and leishmaniasis

Why are shorter, safer and more effective treatments for drug-resistant TB not being rolled out?

Journey of a TB survivor from pain to strength

To View Comments or Join the Conversation:

Tell A Friend